US Patent 7432258 Morpholinyl and pyrrolidinyl analogs
Patent 7432258 was granted and assigned to Smithkline Beecham Limited on October, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Andrew Q. Viet0
Clark A. Sehon0
Gren Z. Wang0
Krista B. Goodman0
Michael J. Neeb0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+322 characters)
Article
Patent abstract
The present invention relates to 4′-[(1R)-1-[[(6,7-dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin- 4-yl)acetyl](methyl)amino]-2-(4-morpholinyl)ethyl]-4-biphenylcarboxylic acid and its pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07432258 Morpholinyl and pyrrolidinyl analogs US Patent 7432258 Morpholinyl and pyrrolidinyl analogs
Infobox
Patent Number
074322580
Patent Number
74322580
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074322580
Date of Patent
October 7, 2008
0Patent Application Number
117805840
Date Filed
July 20, 2007
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07432258 Morpholinyl and pyrrolidinyl analogs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07432258
Date of patent
October 7, 2008
Patent application number
11780584
Date Filed
July 20, 2007
Patent primary examiner
Find more entities like US Patent 7432258 Morpholinyl and pyrrolidinyl analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
